Benzinga | Nov 10, 2021 09:19AM EST

Raymond James Maintains Outperform on Veracyte, Raises Price Target to $62

Raymond James analyst Andrew Cooper maintains Veracyte (NASDAQ:VCYT) with a Outperform and raises the price target from $50 to $62.